PT813870E - Utilizacao da darifenacina para aumentar funcoes cognitivas - Google Patents
Utilizacao da darifenacina para aumentar funcoes cognitivasInfo
- Publication number
- PT813870E PT813870E PT97303879T PT97303879T PT813870E PT 813870 E PT813870 E PT 813870E PT 97303879 T PT97303879 T PT 97303879T PT 97303879 T PT97303879 T PT 97303879T PT 813870 E PT813870 E PT 813870E
- Authority
- PT
- Portugal
- Prior art keywords
- dififenacin
- cognitive functions
- increase cognitive
- darifenacin
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01007—Acetylcholinesterase (3.1.1.7)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Control Of Eletrric Generators (AREA)
- Soil Working Implements (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Chemical Treatment Of Metals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9612710.5A GB9612710D0 (en) | 1996-06-18 | 1996-06-18 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
PT813870E true PT813870E (pt) | 2003-10-31 |
Family
ID=10795468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97303879T PT813870E (pt) | 1996-06-18 | 1997-06-05 | Utilizacao da darifenacina para aumentar funcoes cognitivas |
Country Status (15)
Country | Link |
---|---|
US (1) | US5837724A (pt) |
EP (1) | EP0813870B1 (pt) |
JP (1) | JP3453493B2 (pt) |
KR (1) | KR980000445A (pt) |
AT (1) | ATE243514T1 (pt) |
AU (1) | AU2495697A (pt) |
CA (1) | CA2208111C (pt) |
DE (1) | DE69722999T2 (pt) |
DK (1) | DK0813870T3 (pt) |
ES (1) | ES2197972T3 (pt) |
GB (1) | GB9612710D0 (pt) |
HU (1) | HUP9701060A3 (pt) |
IL (1) | IL121036A0 (pt) |
PT (1) | PT813870E (pt) |
ZA (1) | ZA975311B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
GB0207104D0 (en) * | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
WO2004089892A2 (en) * | 2003-04-01 | 2004-10-21 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
US8404701B2 (en) | 2008-03-27 | 2013-03-26 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
ES2742728T3 (es) | 2009-07-22 | 2020-02-17 | PureTech Health LLC | Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
JP7079777B2 (ja) * | 2017-06-01 | 2022-06-02 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロキノリン誘導体とドネペジルの併用による認知症治療剤 |
WO2020069301A1 (en) | 2018-09-28 | 2020-04-02 | Karuna Therapeutics, Inc. | Compositions and methods for treating disorders ameliorated by muscarnic receptor activation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
-
1996
- 1996-06-18 GB GBGB9612710.5A patent/GB9612710D0/en active Pending
-
1997
- 1997-06-05 PT PT97303879T patent/PT813870E/pt unknown
- 1997-06-05 AT AT97303879T patent/ATE243514T1/de active
- 1997-06-05 DE DE69722999T patent/DE69722999T2/de not_active Expired - Lifetime
- 1997-06-05 EP EP97303879A patent/EP0813870B1/en not_active Expired - Lifetime
- 1997-06-05 DK DK97303879T patent/DK0813870T3/da active
- 1997-06-05 ES ES97303879T patent/ES2197972T3/es not_active Expired - Lifetime
- 1997-06-09 IL IL12103697A patent/IL121036A0/xx unknown
- 1997-06-10 JP JP15189997A patent/JP3453493B2/ja not_active Expired - Lifetime
- 1997-06-11 US US08/872,891 patent/US5837724A/en not_active Expired - Lifetime
- 1997-06-16 CA CA002208111A patent/CA2208111C/en not_active Expired - Lifetime
- 1997-06-17 AU AU24956/97A patent/AU2495697A/en not_active Abandoned
- 1997-06-17 ZA ZA975311A patent/ZA975311B/xx unknown
- 1997-06-17 KR KR1019970025073A patent/KR980000445A/ko not_active Application Discontinuation
- 1997-06-17 HU HU9701060A patent/HUP9701060A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU2495697A (en) | 1998-01-08 |
DE69722999D1 (de) | 2003-07-31 |
CA2208111C (en) | 2002-10-15 |
DE69722999T2 (de) | 2003-12-18 |
CA2208111A1 (en) | 1997-12-18 |
IL121036A0 (en) | 1997-11-20 |
HUP9701060A2 (hu) | 1998-12-28 |
JP3453493B2 (ja) | 2003-10-06 |
HU9701060D0 (en) | 1997-08-28 |
GB9612710D0 (en) | 1996-08-21 |
EP0813870A1 (en) | 1997-12-29 |
ZA975311B (en) | 1998-12-17 |
US5837724A (en) | 1998-11-17 |
EP0813870B1 (en) | 2003-06-25 |
ES2197972T3 (es) | 2004-01-16 |
KR980000445A (ko) | 1998-03-30 |
HUP9701060A3 (en) | 1999-03-29 |
JPH1059848A (ja) | 1998-03-03 |
DK0813870T3 (da) | 2003-08-18 |
ATE243514T1 (de) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9609414B1 (pt) | Combinação de vacina e kit para produzir a mesma. | |
BR9712948B1 (pt) | unidade de terapia por fàtons e cabeÇote para tratamento de terapia de fàtons. | |
PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
DE69533815D1 (de) | Trokaranordnung mit Obturator | |
DE59711118D1 (de) | Spickeln, Zunehmen und Mindern | |
BR9706553A (pt) | Recipiente para tratamento de gás | |
DE69733470D1 (de) | Laserbearbeitung | |
DE3779250D1 (de) | Acrylcopolymere, diese enthaltende hautschutzmittel und ihre anwendung. | |
PT813870E (pt) | Utilizacao da darifenacina para aumentar funcoes cognitivas | |
NO983263D0 (no) | Distribuert behandling | |
DE58902899D1 (de) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer. | |
PT932400E (pt) | Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica | |
DE69524388D1 (de) | 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung | |
PT1052991E (pt) | Utilizacao de loperamida para o tratamento de infeccoes microbianas | |
DE59711240D1 (de) | Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge | |
IT232384Y1 (it) | Apparecchiatura per ipotermia e/o ipertermia terapeutica. | |
DE69906680D1 (de) | Citronnellyl- und/oder dihydrocitronellyllactate, ihre herstellung und ihre anwendung | |
PT661058E (pt) | Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais | |
FR2721490B1 (fr) | Cadre de lit. | |
FI972637A0 (fi) | K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon | |
BR7201475U (pt) | Maquina para fabricacao de absorventes,fraudas e assemelhados | |
ES1030501Y (es) | Apositivo rectal para tratamiento de las hemorroides. | |
DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin | |
ES1034092Y (es) | Juego de impresos perfeccionado para redaccion de contratos, polizas ysimilares. | |
ES1034708Y (es) | Disposicion perfeccionada para la composicion de atlas y similares, en relieve. |